ADVANCED PANCREATIC ADENOCARCINOMA
Clinical trials for ADVANCED PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug cocktail aims to stall pancreatic cancer in patients who have run out of options
Disease control TerminatedThis phase 2 trial tests whether combining two drugs—erlotinib and everolimus—can slow the growth of advanced pancreatic cancer in patients who have already received at least one prior treatment. The study enrolls people with unresectable or metastatic pancreatic adenocarcinoma a…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental pancreatic cancer combo trial halted early
Disease control TerminatedThis study tested an experimental drug called APG-1387 combined with standard chemotherapy (gemcitabine and nab-paclitaxel) in people with advanced pancreatic cancer. The goal was to find the safest dose and see if the combination could shrink tumors. However, the trial was termi…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC